News
Vaxcyte's pneumococcal jab exceeds expectations
Shares in Vaxcyte have rocketed on phase 3 trial data for its pneumococcal vaccine VAX-31 that suggests it could take on rivals from Pfizer and MSD.
News
Nobel Prize in Medicine awarded to optogenetics trio
The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to optogenetics pioneers Karl Deisseroth, Peter Hegemann, and Georg Nagel.
R&D
The hidden pandemic within the pandemic: How COVID-19 impact...
Why sepsis readiness – equipment, supply chains, surveillance, and public awareness – needs to be treated as core pandemic infrastructure.
News
CSL joins forces with Alentis on claudin candidate
CSL has licensed rights to a potentially first-in-class anti-claudin-1 antibody developed by Alentis in a deal that could be worth up to $1.55bn.
News
Novartis taps China's Abogen for autoimmunity TCE
Novartis has added a T-cell engager developed by China's Abogen Biosciences for autoimmune disorders in a deal that could be worth over $7.5bn.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
